Adagene (ADAG) Short Interest Ratio & Short Volume $1.98 -0.04 (-1.98%) As of 01/6/2025 03:59 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Adagene Short Interest DataAdagene (ADAG) has a short interest of 65,300 shares, representing 0.18% of the float (the number of shares available for trading by the public). This marks a 88.18% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 14,027 shares to cover all short positions.Current Short Interest65,300 sharesPrevious Short Interest34,700 sharesChange Vs. Previous Month+88.18%Dollar Volume Sold Short$134,518.00Short Interest Ratio1.1 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares44,271,000 sharesFloat Size37,280,000 sharesShort Percent of Float0.18%Today's Trading Volume18,082 sharesAverage Trading Volume14,027 sharesToday's Volume Vs. Average129% Short Selling Adagene? Sign up to receive the latest short interest report for Adagene and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartADAG Short Interest Over TimeADAG Days to Cover Over TimeADAG Percentage of Float Shorted Over Time Ad Paradigm Press Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!Click here now for the urgent details. Adagene Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/202465,300 shares $134,518.00 +88.2%0.2%1.1 $2.06 11/30/202434,700 shares $81,024.50 +2,213.3%0.1%0.5 $2.34 11/15/20241,500 shares $3,240.00 -87.8%N/A0 $2.16 10/31/202412,300 shares $35,055.00 -42.5%0.0%0.1 $2.85 10/15/202421,400 shares $51,146.00 -30.7%0.1%0.3 $2.39 9/30/202430,900 shares $68,598.00 +153.3%0.1%0.4 $2.22 Get the Latest News and Ratings for ADAG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adagene and its competitors with MarketBeat's FREE daily newsletter. 9/15/202412,200 shares $42,578.00 -2.4%0.0%0.2 $3.49 8/31/202412,500 shares $35,000.00 -3.9%0.0%0.2 $2.80 8/15/202413,000 shares $33,670.00 +170.8%0.0%0.3 $2.59 7/31/20244,800 shares $11,712.00 -34.3%0.0%0.2 $2.44 7/15/20247,300 shares $19,929.00 -62.9%0.0%0.2 $2.73 6/30/202419,700 shares $60,301.70 +45.9%0.1%0.6 $3.06 6/15/202413,500 shares $36,180.00 +400.0%0.0%0.4 $2.68 5/31/20242,700 shares $6,831.00 -75.7%0.0%0.1 $2.53 5/15/202411,100 shares $29,526.00 -26.5%0.0%0.3 $2.66 4/30/202415,100 shares $34,126.00 +6.3%0.0%0.6 $2.26 4/15/202414,200 shares $36,920.00 +3.7%0.0%0.3 $2.60 3/31/202413,700 shares $38,360.00 -38.6%0.0%0.1 $2.80 3/15/202422,300 shares $63,443.50 +9.9%0.1%0.2 $2.85 2/29/202420,300 shares $64,960.00 -7.3%0.1%0.2 $3.20 2/15/202421,900 shares $76,650.00 -50.9%0.1%0.2 $3.50 1/31/202444,600 shares $163,236.00 +105.5%0.1%0.4 $3.66 1/15/202421,700 shares $68,789.00 -13.9%0.1%0.2 $3.17 12/31/202325,200 shares $48,671.28 -23.2%0.1%0.8 $1.93 12/15/202332,800 shares $50,184.00 +47.8%0.1%1.5 $1.53 11/30/202322,200 shares $38,850.00 +0.5%0.1%1.2 $1.75 11/15/202322,100 shares $30,056.00 +0.9%0.1%1.5 $1.36 10/31/202321,900 shares $29,674.50 -9.5%0.1%1.4 $1.36 10/15/202324,200 shares $34,122.00 -4.0%0.1%1.4 $1.41 9/30/202325,200 shares $38,556.00 +0.4%0.1%1.4 $1.53 9/15/202325,100 shares $35,642.00 -14.0%0.1%1.1 $1.42 8/31/202329,200 shares $39,712.00 +4.3%0.1%1.1 $1.36 8/15/202328,000 shares $37,240.00 +42.1%0.1%1.1 $1.33 7/31/202319,700 shares $26,792.00 +8.2%0.1%0.8 $1.36 7/15/202318,200 shares $26,572.00 -34.1%0.0%0.7 $1.46 6/30/202327,600 shares $39,192.00 +200.0%0.1%1.1 $1.42 6/15/20239,200 shares $12,696.00 -48.9%0.0%0.6 $1.38 5/31/202318,000 shares $24,120.00 -8.2%0.0%1.6 $1.34 5/15/202319,600 shares $26,068.00 +108.5%0.1%1.8 $1.33 4/30/20239,400 shares $12,314.00 -9.6%0.0%0.8 $1.31Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 4/15/202310,400 shares $15,496.00 -28.8%0.0%0.7 $1.49 3/31/202314,600 shares $21,170.00 +44.6%0.0%0.7 $1.45 3/15/202310,100 shares $16,160.00 +23.2%0.0%0.4 $1.60 2/28/20238,200 shares $13,642.34 -10.9%0.0%0.2 $1.66 2/15/20239,200 shares $17,342.00 -24.0%0.0%0.2 $1.89 1/31/202312,100 shares $23,232.00 -38.3%0.0%0.2 $1.92 1/15/202319,600 shares $34,888.00 -59.9%0.1%0.3 $1.78 12/30/202248,900 shares $64,792.50 -63.9%0.1%0.7 $1.33 12/15/2022135,300 shares $178,596.00 +30.9%0.3%2 $1.32 11/30/2022103,400 shares $111,672.00 -7.2%0.3%1.8 $1.08 11/15/2022111,400 shares $132,566.00 +17.8%0.3%2 $1.19 10/31/202294,600 shares $85,140.00 +56.6%0.2%1.5 $0.90 10/15/202260,400 shares $79,124.00 -5.0%0.2%1.2 $1.31 9/30/202263,600 shares $81,408.00 +8.7%0.2%1.3 $1.28 9/15/202258,500 shares $83,070.00 -9.3%0.1%0.8 $1.42 8/31/202264,500 shares $94,170.00 -21.2%0.2%0.7 $1.46 8/15/202281,800 shares $114,520.00 +19.9%0.2%0.9 $1.40 7/31/202268,200 shares $115,258.00 -4.2%0.2%0.9 $1.69 7/15/202271,200 shares $137,772.00 +37.7%0.2%1.1 $1.94 6/30/202251,700 shares $107,019.00 -4.3%0.1%0.8 $2.07 6/15/202254,000 shares $108,000.00 -13.7%0.1%1.1 $2.00 5/31/202262,600 shares $175,280.00 -18.0%0.2%1.9 $2.80 5/15/202276,300 shares $243,397.00 -3.4%0.2%1.9 $3.19 4/30/202279,000 shares $288,350.00 -2.8%0.2%2.1 $3.65 4/15/202281,300 shares $301,623.00 +6.4%0.2%2.2 $3.71 3/31/202276,400 shares $267,400.00 -11.5%0.2%2.2 $3.50 3/15/202286,300 shares $418,555.00 -0.9%0.2%3 $4.85 2/28/202287,100 shares $473,824.00 -1.8%0.2%3.4 $5.44 2/15/202288,700 shares $584,905.54 -9.8%0.2%4.7 $6.59 1/31/202298,300 shares $711,692.00 +7.3%0.2%4.9 $7.24 1/15/202291,600 shares $749,746.00 +5.8%0.2%4.6 $8.19 12/31/202186,600 shares $698,723.44 -23.3%0.2%4 $8.07 12/15/2021112,900 shares $1.01 million -20.3%0.3%5.1 $8.99 11/30/2021141,600 shares $1.16 million -1.3%0.4%6.2 $8.22 11/15/2021143,500 shares $1.48 million -3.4%0.4%7 $10.29 10/29/2021148,500 shares $1.67 million -27.5%0.4%7.4 $11.24 10/15/2021204,700 shares $2.39 million -4.3%0.5%8 $11.70 9/30/2021213,900 shares $3.07 million +18.2%0.5%6.6 $14.37 9/15/2021180,900 shares $2.76 million -28.6%0.4%4.8 $15.25 8/31/2021253,500 shares $4.10 million -17.5%0.6%7.1 $16.16 8/13/2021307,100 shares $5.68 million No Change0.7%6.3 $18.50 ADAG Short Interest - Frequently Asked Questions What is Adagene's current short interest? Short interest is the volume of Adagene shares that have been sold short but have not yet been closed out or covered. As of December 15th, investors have sold 65,300 shares of ADAG short. 0.18% of Adagene's shares are currently sold short. Learn More on Adagene's current short interest. What is a good short interest ratio for Adagene? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADAG shares currently have a short interest ratio of 1.0. Learn More on Adagene's short interest ratio. What is a good short interest percentage for Adagene? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.18% of Adagene's floating shares are currently sold short. Is Adagene's short interest increasing or decreasing? Adagene saw a increase in short interest in the month of December. As of December 15th, there was short interest totaling 65,300 shares, an increase of 88.2% from the previous total of 34,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Adagene's float size? Adagene currently has issued a total of 44,271,000 shares. Some of Adagene's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Adagene currently has a public float of 37,280,000 shares. How does Adagene's short interest compare to its competitors? 0.18% of Adagene's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Adagene: Design Therapeutics, Inc. (8.60%), Valneva SE (0.03%), Y-mAbs Therapeutics, Inc. (9.73%), Kamada Ltd. (0.06%), Eton Pharmaceuticals, Inc. (1.07%), Corvus Pharmaceuticals, Inc. (6.71%), Tango Therapeutics, Inc. (16.28%), Sage Therapeutics, Inc. (11.90%), Neurogene Inc. (9.89%), biote Corp. (2.49%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Adagene stock? Short selling ADAG is an investing strategy that aims to generate trading profit from Adagene as its price is falling. ADAG shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adagene? A short squeeze for Adagene occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADAG, which in turn drives the price of the stock up even further. How often is Adagene's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADAG, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies Design Therapeutics Short Squeeze Valneva Short Squeeze Y-mAbs Therapeutics Short Squeeze Kamada Short Squeeze Eton Pharmaceuticals Short Squeeze Corvus Pharmaceuticals Short Squeeze Tango Therapeutics Short Squeeze Sage Therapeutics Short Squeeze Neurogene Short Squeeze biote Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADAG) was last updated on 1/7/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredElon Musk says U.S. government is going bankruptIn 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adagene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adagene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADAG Stock Alerts